Journal Club XIV: SAVANT

Please join ISCPh and pharmacy student Kyle Valker as we discuss the SAVANT trial and post-hoc analysis. 

This event is free for members and $10 for non-members and will be recorded for those unable to join us live. 

Here are the articles that we will be reviewing during this journal club:

Original article: Sativex as add on therapy vs further optimized first line ANTispastics SAVANT in resistant multiple sclerosis spasticity a double blind placebo.pdf

Post-hoc analysis: Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity consistency of response across subgroups from the.pdf

Please RSVP to receive the Zoom Link!